1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017


DelveInsight’s Report, “Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Pancreatic Cancer Report is to understand the market and pipeline status of the drugs around the Pancreatic Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Pancreatic Cancer. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Pancreatic Cancer.
- A review of the marketed products under prescription for Pancreatic Cancer, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Pancreatic Cancer with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Pancreatic Cancer drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Pancreatic Cancer drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Pancreatic Cancer drugs.
- Coverage of Pancreatic Cancer Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Pancreatic Cancer key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Pancreatic Cancer.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Pancreatic Cancer.
- API intelligence over marketed drugs forPancreatic Cancerand gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Pancreatic Cancer.
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Illustrative
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Pancreatic Cancer
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Pancreatic Cancer
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Pancreatic Cancer
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer


List of Tables

- Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Application Type, 2017
- Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
- Pancreatic Cancer Therapeutic Market, US, (Year), 2017
- Pancreatic Cancer Marketed Drugs, API Manufacturers by US DMF Status, 2017
- Pancreatic Cancer Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Pancreatic Cancer Drugs, API Manufacturers, Europe by Country, 2017
- Pancreatic Cancer Drugs, API Manufacturers, India by State, 2017
- Pancreatic Cancer Drugs, API Manufacturers, China by Province, 2017
- Pancreatic Cancer Drugs, API Manufacturers by Geography 2017
- Pancreatic Cancer Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Pancreatic Cancer Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2017
- Phase III Drugs for Pancreatic Cancer, 2017
- Discontinued Drugs for Pancreatic Cancer, 2017


List of Figures

- Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
- Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
- Pancreatic Cancer Therapeutic Market, US, (Year), 2017
- Pancreatic Cancer Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
- Pancreatic Cancer Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Pancreatic Cancer Drugs, API Manufacturers, Europe by Country, 2017
- Pancreatic Cancer Drugs, API Manufacturers, India by State, 2017
- Pancreatic Cancer Drugs, API Manufacturers, China by Province, 2017
- Pancreatic Cancer Drugs, API Manufacturers by Geography 2017
- Pancreatic Cancer Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Pancreatic Cancer Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

North America Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2016 - 2021)

North America Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2016 - 2021)

  • $ 3850
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The North American pancreatic cancer market is expected to grow modestly from USD XX million in 2016 to USD XX million in 2021, at a CAGR of XX%. Globally, pancreatic cancer is the 12th most common cance ...

Global Pancreatic Cancer Market Research Report 2016

Global Pancreatic Cancer Market Research Report 2016

  • $ 2850
  • Industry report
  • December 2016
  • by 9Dimen Research

2016 Global Pancreatic Cancer Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Pancreatic Cancer industry, focusing on the main regions ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics and Autoimmune Disease Statistics in the US

  • January 2017
    152 pages
  • Cancer  

    Autoimmune Dise...  

    Dermatological ...  

  • United States  

View report >

Cancer Statistics in the US and Denmark

  • January 2017
    18 pages
  • Cancer  

  • United States  

    Denmark  

View report >

Breast Cancer Statistics in the US

  • January 2017
    30 pages
  • Breast Cancer  

    Cancer  

    Ovarian Cancer  

  • United States  

View report >

Cancer Statistics

1 month ago

Related Market Segments :

Pancreatic Cancer
Cloud Computing

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.